Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience
Articolo
Data di Pubblicazione:
2017
Citazione:
Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience / Olivera, P; Thiriet, L; Luc, A; Baumann, C; Danese, S; Peyrin-Biroulet, L. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 23:6(2017), pp. 976-985. [10.1097/MIB.0000000000001072]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Olivera, P; Thiriet, L; Luc, A; Baumann, C; Danese, S; Peyrin-Biroulet, L
Link alla scheda completa:
Pubblicato in: